VYNE Therapeutics Ownership | Who Owns VYNE Therapeutics?

VYNE Therapeutics Ownership Summary

VYNE Therapeutics is owned by 18.86% institutional investors, 5.38% insiders, and 75.76% retail investors. Cormorant asset management, lp is the largest institutional shareholder, holding 3.21% of VYNE shares. Kennedy Micro Cap Opportunities is the top mutual fund, with 2.96% of its assets in VYNE Therapeutics shares.

VYNE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	VYNE Therapeutics	18.86%	5.38%	75.76%
Sector	Healthcare Stocks	486.50%	11.08%	-397.59%
Industry	Biotech Stocks	304.14%	11.08%	-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Cormorant asset management, lp	1.37M	3.21%	$2.26M
Adage capital partners gp	644.13K	1.51%	$1.06M
Dafna capital management	636.10K	1.49%	$1.05M
Kennedy capital management	570.74K	1.34%	$941.72K
Palo alto investors lp	445.43K	1.04%	$734.97K
Patient square capital lp	317.03K	0.74%	$523.10K
Ikarian capital	290.00K	0.68%	$478.50K
Boothbay fund management	106.46K	0.25%	$175.66K
Prelude capital management	64.58K	0.15%	$106.56K
Xtx topco	56.91K	0.13%	$93.90K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Dafna capital management	636.10K	0.29%	$1.05M
Patient square capital lp	317.03K	0.19%	$523.10K
Cormorant asset management, lp	1.37M	0.17%	$2.26M
Palo alto investors lp	445.43K	0.16%	$734.97K
Ikarian capital	290.00K	0.09%	$478.50K
Kennedy capital management	570.74K	0.02%	$941.72K
Harvest investment services	51.33K	0.02%	$84.69K
Prelude capital management	64.58K	0.01%	$106.56K
Staley capital advisers	36.47K	0.01%	$122.18K
Xtx topco	56.91K	0.00%	$93.90K

Top Buyers

Holder	Shares	% Assets	Change
Cormorant asset management, lp	1.37M	0.17%	1.37M
Kennedy capital management	570.74K	0.02%	570.74K
Adage capital partners gp	644.13K	0.00%	300.00K
Ikarian capital	290.00K	0.09%	290.00K
Boothbay fund management	106.46K	0.00%	106.46K

Top Sellers

Holder	Shares	% Assets	Change
Eventide asset management	-	-	-1.39M
Parkman healthcare partners	-	-	-217.98K
Prelude capital management	64.58K	0.01%	-76.92K
Adar1 capital management	-	-	-70.42K
Ubs oconnor	-	-	-45.56K

New Positions

Holder	Shares	% Assets	Change	Value
Kennedy capital management	570.74K	0.02%	570.74K	$941.72K
Ikarian capital	290.00K	0.09%	290.00K	$478.50K
Boothbay fund management	106.46K	0.00%	106.46K	$175.66K
Harvest investment services	51.33K	0.02%	51.33K	$84.69K
Acadian asset management	22.42K	0.00%	22.42K	$36.00K

Sold Out

Holder	Change
Cornerstone planning group	-2.00
Ashton thomas private wealth	-19.00
Ubs group	-7.58K
Shay capital	-18.02K
Virtu financial	-19.57K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	44	15.79%	8,048,768	12.39%	18	6.70%	22	-	12	71.43%
Mar 31, 2025	38	8.57%	7,161,761	1.37%	16	6.10%	22	15.79%	7	16.67%
Dec 31, 2024	1	-	36,472	-	-	1168.22%	-	-	-	-
Sep 30, 2024	1	-50.00%	36,472	-0.05%	-	1166.04%	-	-100.00%	-	-
Jun 30, 2024	2	-	36,491	0.05%	-	68.00%	1	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Kennedy Micro Cap Opportunities	493.02K	2.96%	493.02K
Vanguard US Total Market Shares ETF	373.32K	2.45%	-
Vanguard Total Stock Mkt Idx Inv	365.33K	2.19%	-7.99K
AlphaCentric LifeSci Healthcare I	310.50K	2.11%	-134.50K
AlphaCentric Life Sciences & Hlthcare I	268.49K	1.82%	-42.02K
Pleiades Small Cap Equity A	149.44K	0.90%	149.44K
Vanguard Institutional Extnd Mkt Idx Tr	130.10K	0.78%	8.12K
AZ Equity Biotechnology A-AZ EUR Acc	91.08K	0.55%	2.50K
Fidelity Extended Market Index	69.15K	0.41%	-
Bridgeway Ultra-Small Company	76.96K	0.39%	25.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 15, 2025	LEPORE PATRICK G	-	Buy	$43.80K
Nov 15, 2023	LEPORE PATRICK G	-	Buy	$50.78K
Mar 20, 2023	LEPORE PATRICK G	-	Buy	$49.68K
Mar 20, 2023	Harsch Mutya	Chief Legal Officer and GC	Buy	$25.00K
Nov 30, 2021	LEPORE PATRICK G	-	Buy	$12.70K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	1	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-

VYNE Ownership FAQ

Who Owns VYNE Therapeutics?

VYNE Therapeutics shareholders are primarily institutional investors at 18.86%, followed by 5.38% insiders and 75.76% retail investors. The average institutional ownership in VYNE Therapeutics's industry, Biotech Stocks , is 304.14%, which VYNE Therapeutics falls below.

Who owns the most shares of VYNE Therapeutics?

VYNE Therapeutics’s largest shareholders are Cormorant asset management, lp (1.37M shares, 3.21%), Adage capital partners gp (644.13K shares, 1.51%), and Dafna capital management (636.1K shares, 1.49%). Together, they hold 6.21% of VYNE Therapeutics’s total shares outstanding.

Does Blackrock own VYNE Therapeutics?

BlackRock is not among the top 10 institutional shareholders of VYNE Therapeutics.

Who is VYNE Therapeutics’s biggest shareholder by percentage of total assets invested?

Dafna capital management is VYNE Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.29% of its assets in 636.1K VYNE Therapeutics shares, valued at 1.05M$.

Who is the top mutual fund holder of VYNE Therapeutics shares?

Kennedy Micro Cap Opportunities is the top mutual fund holder of VYNE Therapeutics shares, with 2.96% of its total shares outstanding invested in 493.02K VYNE Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools